Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4291)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 15, 2022 (publication date) through Jul 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh AK, Singh R. Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors. World J Diabetes 2022; 13(6): 466-470 [PMID: 35800411 DOI: 10.4239/wjd.v13.i6.466] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i6/466.htm |
| Number | Citing Articles |
| 1 |
Sanjay Kalra, Saptarshi Bhattacharya, A Dhingra, Sambit Das, Nitin Kapoor, Shehla Shaikh, Vivek Kolapkar, R V Lokesh Kumar, Kamlesh Patel, Rahul Kotwal. Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India. Cureus 2024; doi: 10.7759/cureus.61766
|